Aytu BioScience(DE:AY20)
€1.760.00 (0.00%)
DE:AY20
Aytu BioScience Revenue
€1.76
At close:0.00 (0.00%)
Aytu BioScience (AY20) Revenue
0 Followers
Aytu BioScience Revenue
Aytu BioScience had a revenue of 16.11M in the quarter ending Jun 30, 2026, with 29.77%. This bring the company's revenue in the last twelve months to 57.57M, Increased 1.72%. In the fiscal year ending Jun 30, 2026, Aytu BioScience had annual revenue of 57.57M with -13.27% growth.
- Revenue (ttm)
- 57.57M
- Revenue Growth
- ―
- P/S Ratio
- 0.31
- Revenue/Employee
- EUR 757,500
- Employees
- 76
- Market Cap
- EUR 17.73M
Revenue Chart
Aytu BioScience Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 57.57M | -8.81M | -13.27% |
| Jun 30, 2025 | 66.38M | 1.20M | 1.84% |
| Jun 30, 2024 | 65.18M | -42.22M | -39.31% |
| Jun 30, 2023 | 107.40M | 10.73M | 11.10% |
| Jun 30, 2022 | 96.67M | 31.04M | 47.29% |
| Jun 30, 2021 | 65.63M | 38.00M | 137.52% |
| Sep 30, 2020 | 27.63M | 20.31M | 277.47% |
| Jun 30, 2019 | 7.32M | 3.66M | 100.01% |
| Jun 30, 2018 | 3.66M | 438.41K | 13.61% |
| Jun 30, 2017 | 3.22M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.